FOSUN PHARMA - An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

make any statement and expressly disclaim any liability for any damages whatsoever arising from or in reliance upon the whole or any part of the contents of this announcement. assumes no responsibility for any failure. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* (a joint stock limited company incorporated in the People's Republic of China) (Stock code: 02196) Overseas regulatory announcement This announcement is made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. This is to set forth the "Shanghai Fosun Pharmaceutical (Group) Co., Ltd." ("Company") published on the website of the Shanghai Stock Exchange "Annual Report Work Procedures of the Audit Committee of the Board of Directors of Fosun Pharma (Group) Co., Ltd. (Revised in 2026)" is for reference only. By order of the board of directors Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Chairman Chen Yuqing China, Shanghai March 24, 2026 As at the date of this announcement, the executive directors of the Company are Mr. Chen Yuqing, Ms. Guan Xiaohui, Mr. Wen Deyong, Mr. Wang Kexin and Mr. Liu Yi; the Company The non-executive directors of the company are Mr. Chen Qiyu and Mr. Pan Donghui; the independent non-executive directors of the company are Mr. Yu Zishan, Mr. Wang Quandi, and Mr. Chen Mr. Penghui and Mr. Yang Yucheng; and the employee director of the Company is Ms. Yan Jia. *For identification only Shanghai Shanghai Fufu Xingxing Medical and Pharmaceutical ((Group)) Co., Ltd. Board of Directors Audit Planning Committee Meeting Annual Report Work Rules and Procedures ((Revised in 22002266)) Article 1 In order to give full play to Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as "the Company") "Company") Board of Directors (hereinafter referred to as the "Board") Audit Committee (hereinafter referred to as the "Audit Committee") The supervisory role of the company's annual report is specially formulated in accordance with the relevant regulations of the China Securities Regulatory Commission and other this regulation. Article 22 During the preparation and disclosure process of the company's annual report, members of the audit committee shall comply with relevant laws and regulations. laws, administrative regulations, departmental rules and the Articles of Association of Shanghai Fosun Pharma (Group) Co., Ltd. (hereinafter referred to as (hereinafter referred to as the "Articles of Association")), conscientiously perform their duties, carry out work diligently and responsibly, and safeguard the integrity of the company. overall interests of the company. Article 33 When a company discloses its annual report in accordance with the relevant regulations of the Shanghai Stock Exchange, it shall also disclose The annual performance of duties of the Audit Committee, mainly including its performance of duties and exercise of powers, the Audit Committee The convening of meetings, etc. The audit committee shall disclose the schedule of the company’s annual report and the actual situation. situation, negotiate with the accounting firm to determine the timetable for the audit of the annual financial report; the audit committee should When urging accounting firms to submit audit reports within the agreed time. Article 44 The audit committee shall consult with the certified public accountant who provides the company with the annual report audit (hereinafter referred to as the "annual report"). Audit accountants") review the unaudited financial statements prepared by the company and the accounting firm before entering the site. Carry out the work plan for the company's audit for this year and formulate written opinions. Article 55 After the annual audit accountant enters the scene, the audit committee shall strengthen communication with the annual audit accountant. in After the annual audit accountant issues a preliminary audit opinion, the audit committee shall hold a meeting and communication with the annual audit accountant. meeting, once again review the company's financial accounting statements and form written opinions. Article 66 After completing the audit of the annual financial accounting report, the audit committee shall respond to the annual financial accounting report Voting is conducted and a resolution is formed and submitted to the board of directors for review. Article 77 The audit committee shall regularly submit to the board of directors the performance of its duties by the external audit institution hired. evaluation reports and reports on the performance of supervisory responsibilities by external audit institutions. When the audit committee re-appoints the accounting firm for the annual audit for the next year, it shall complete the annual audit accounting firm for the current year. Make a comprehensive and objective evaluation of the audit work and quality of practice, and submit it to the directors after reaching a positive opinion After deliberation by the board of directors, it will be submitted to the shareholders' meeting for deliberation; if a negative opinion is formed, an accountant should be hired instead. Office. When the audit committee appoints an accounting firm for the next year's annual audit, it should communicate through face-to-face meetings. Conduct a comprehensive understanding and appropriate evaluation of the predecessor and the accounting firm to be hired, and formulate opinions before submitting them to the board of directors for review. After deliberation and approval by the board of directors, it will be submitted to the shareholders' meeting for review. Article 88 During the preparation of the annual report, the company shall actively create opportunities for the audit committee to perform the above responsibilities. necessary conditions. Article 99 During the preparation and review of the annual report, members of the audit committee shall have the obligation to keep confidentiality. in the year Before the annual report is announced, the contents of the annual report shall not be disclosed to the outside world in any form or through any channel. in the year During the preparation process of the report, the audit committee should urge the accounting firm and relevant personnel to fulfill their confidentiality obligations. We should strictly prevent the leakage of inside information, insider trading and other illegal activities. Article 10 Matters not covered in these regulations may be inconsistent with relevant laws, administrative regulations, departmental rules, company stock If there is any conflict with the provisions of the securities regulatory authority at the place of listing and the Articles of Association, the laws, administrative regulations, and ministry regulations shall be followed. The company shall comply with the relevant regulations of the regulatory authorities, the securities regulatory authorities of the place where the company’s shares are listed, and the Articles of Association. Article 11 These regulations shall take effect from the date of review and approval by the board of directors, and the same shall apply when revised. Article 122 The Board of Directors is responsible for the interpretation of these Regulations. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. March 24, 2026